For richer, for poorer, in sickness and in health: The entanglement of science and marketing

Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical indus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Australian and New Zealand journal of psychiatry 2012-06, Vol.46 (6), p.498-500
1. Verfasser: Smith, Geoffrey P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 500
container_issue 6
container_start_page 498
container_title Australian and New Zealand journal of psychiatry
container_volume 46
creator Smith, Geoffrey P
description Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.
doi_str_mv 10.1177/0004867412446492
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1019617894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0004867412446492</sage_id><sourcerecordid>1019617894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</originalsourceid><addsrcrecordid>eNp1kL1PwzAQxS0EoqWwM6FILAwE_BV_sKGKAhISS9mQIje5NGlTp9iJBPz1OKQwILH4nX2_ez49hE4JviJEymuMMVdCckI5F1zTPTQmnOOYCML30bhvx31_hI68X2FMGEnkIRpRKqSmmI7R66xxkauyEtxlVIR62zSurysb-SpbW_A-Mjbv7yWYui1vonkJEdjW2GUNm1BETRH5rAKbwTe6MW4NbWWXx-igMLWHk51O0Mvsbj59iJ-e7x-nt09xxkTSxloYnAujQUmTELzQCjDRKkh41EqEpXnBEgGZEHzBGAYhDFNMyYRQ4DmboIvBd-uatw58m24qn0FdGwtN51MS7ASRSvOA4gHNXOO9gyLduios_BGgtM80_ZtpGDnbuXeLDeS_Az8hBuB8AGxtP9PK5vAeVGvJEk4VEzgcMlDxQHmzhHTVdM6GTP7_9gvOHYay</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1019617894</pqid></control><display><type>article</type><title>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Smith, Geoffrey P</creator><creatorcontrib>Smith, Geoffrey P</creatorcontrib><description>Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><identifier>ISSN: 0004-8674</identifier><identifier>EISSN: 1440-1614</identifier><identifier>DOI: 10.1177/0004867412446492</identifier><identifier>PMID: 22679202</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Australia ; Bias ; Conflict of Interest ; Conflict of interests ; Drug Industry - economics ; Drug Industry - ethics ; Drug Industry - standards ; Drugs ; Ethics, Research ; Finance ; Humans ; Interprofessional Relations - ethics ; Marketing ; Marketing - ethics ; Medicine ; Moral and ethical aspects ; Pharmaceutical ethics ; Professional ethics ; Psychiatrists ; Psychiatry - ethics ; Research Support as Topic - ethics</subject><ispartof>Australian and New Zealand journal of psychiatry, 2012-06, Vol.46 (6), p.498-500</ispartof><rights>The Royal Australian and New Zealand College of Psychiatrists 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</citedby><cites>FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0004867412446492$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0004867412446492$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21817,27922,27923,43619,43620</link.rule.ids><backlink>$$Uhttps://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,997354283602837&amp;tab=innz&amp;search_scope=INNZ&amp;vid=NLNZ&amp;offset=0$$DView this record in NLNZ$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22679202$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Geoffrey P</creatorcontrib><title>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</title><title>Australian and New Zealand journal of psychiatry</title><addtitle>Aust N Z J Psychiatry</addtitle><description>Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><subject>Australia</subject><subject>Bias</subject><subject>Conflict of Interest</subject><subject>Conflict of interests</subject><subject>Drug Industry - economics</subject><subject>Drug Industry - ethics</subject><subject>Drug Industry - standards</subject><subject>Drugs</subject><subject>Ethics, Research</subject><subject>Finance</subject><subject>Humans</subject><subject>Interprofessional Relations - ethics</subject><subject>Marketing</subject><subject>Marketing - ethics</subject><subject>Medicine</subject><subject>Moral and ethical aspects</subject><subject>Pharmaceutical ethics</subject><subject>Professional ethics</subject><subject>Psychiatrists</subject><subject>Psychiatry - ethics</subject><subject>Research Support as Topic - ethics</subject><issn>0004-8674</issn><issn>1440-1614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1PwzAQxS0EoqWwM6FILAwE_BV_sKGKAhISS9mQIje5NGlTp9iJBPz1OKQwILH4nX2_ez49hE4JviJEymuMMVdCckI5F1zTPTQmnOOYCML30bhvx31_hI68X2FMGEnkIRpRKqSmmI7R66xxkauyEtxlVIR62zSurysb-SpbW_A-Mjbv7yWYui1vonkJEdjW2GUNm1BETRH5rAKbwTe6MW4NbWWXx-igMLWHk51O0Mvsbj59iJ-e7x-nt09xxkTSxloYnAujQUmTELzQCjDRKkh41EqEpXnBEgGZEHzBGAYhDFNMyYRQ4DmboIvBd-uatw58m24qn0FdGwtN51MS7ASRSvOA4gHNXOO9gyLduios_BGgtM80_ZtpGDnbuXeLDeS_Az8hBuB8AGxtP9PK5vAeVGvJEk4VEzgcMlDxQHmzhHTVdM6GTP7_9gvOHYay</recordid><startdate>201206</startdate><enddate>201206</enddate><creator>Smith, Geoffrey P</creator><general>SAGE Publications</general><scope>DUNLO</scope><scope>GOM</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201206</creationdate><title>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</title><author>Smith, Geoffrey P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Australia</topic><topic>Bias</topic><topic>Conflict of Interest</topic><topic>Conflict of interests</topic><topic>Drug Industry - economics</topic><topic>Drug Industry - ethics</topic><topic>Drug Industry - standards</topic><topic>Drugs</topic><topic>Ethics, Research</topic><topic>Finance</topic><topic>Humans</topic><topic>Interprofessional Relations - ethics</topic><topic>Marketing</topic><topic>Marketing - ethics</topic><topic>Medicine</topic><topic>Moral and ethical aspects</topic><topic>Pharmaceutical ethics</topic><topic>Professional ethics</topic><topic>Psychiatrists</topic><topic>Psychiatry - ethics</topic><topic>Research Support as Topic - ethics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Geoffrey P</creatorcontrib><collection>Index New Zealand (A&amp;I)</collection><collection>Index New Zealand</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Australian and New Zealand journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Geoffrey P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</atitle><jtitle>Australian and New Zealand journal of psychiatry</jtitle><addtitle>Aust N Z J Psychiatry</addtitle><date>2012-06</date><risdate>2012</risdate><volume>46</volume><issue>6</issue><spage>498</spage><epage>500</epage><pages>498-500</pages><issn>0004-8674</issn><eissn>1440-1614</eissn><abstract>Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>22679202</pmid><doi>10.1177/0004867412446492</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0004-8674
ispartof Australian and New Zealand journal of psychiatry, 2012-06, Vol.46 (6), p.498-500
issn 0004-8674
1440-1614
language eng
recordid cdi_proquest_miscellaneous_1019617894
source MEDLINE; SAGE Complete A-Z List
subjects Australia
Bias
Conflict of Interest
Conflict of interests
Drug Industry - economics
Drug Industry - ethics
Drug Industry - standards
Drugs
Ethics, Research
Finance
Humans
Interprofessional Relations - ethics
Marketing
Marketing - ethics
Medicine
Moral and ethical aspects
Pharmaceutical ethics
Professional ethics
Psychiatrists
Psychiatry - ethics
Research Support as Topic - ethics
title For richer, for poorer, in sickness and in health: The entanglement of science and marketing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T16%3A17%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=For%20richer,%20for%20poorer,%20in%20sickness%20and%20in%20health:%20The%20entanglement%20of%20science%20and%20marketing&rft.jtitle=Australian%20and%20New%20Zealand%20journal%20of%20psychiatry&rft.au=Smith,%20Geoffrey%20P&rft.date=2012-06&rft.volume=46&rft.issue=6&rft.spage=498&rft.epage=500&rft.pages=498-500&rft.issn=0004-8674&rft.eissn=1440-1614&rft_id=info:doi/10.1177/0004867412446492&rft_dat=%3Cproquest_cross%3E1019617894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1019617894&rft_id=info:pmid/22679202&rft_sage_id=10.1177_0004867412446492&rfr_iscdi=true